|
|
细胞自噬在前列腺疾病中的研究进展 |
李剑;刘荣福 |
厦门大学附属第一医院泌尿外科,福建 厦门 361003 |
|
[1] Bennett HL, Stockley J, Fleming JT, et al. Does androgen-ablation therapy(AAT) associated autophagy have a prosurvival effect in LNCaP human prostate cancer cells [J]. BJU Int, 2013,111(4):672-682. [2] Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion[J]. Nature,2008,451(7182):1060-1075. [3] Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations[J]. Cell Biol,2007,9(10):1102-1109. [4] Mǔzes G, Sipos F. Tumorigenesis: interplay of pattern recognition receptors and autophagy[J]. Magy Onkol,2016,60(1):55-63. [5] Leone RD, Amaravadi RK. Autophagy:a targetable linchpin of cancer cell metabolism[J]. Trends Endocrinol Metab,2013,24(4):209-217. [6] Farrow JM, Yang JC, Evans CP. Autophagy as a modulator and target in prostate cancer[J]. Nat Rev Urol,2014,11(9):508-516. [7] Cheong H, Lu C, Lindsten T, et al. Therapeutic targets in cancer cell metabolism and autophagy[J]. Nat Biotechnol,2012,30(7):671-678. [8] 向波,易梅,李小玲,等. 细胞自噬在肿瘤发生发展中的作用[J]. 生物化学与生物物理进展,2012,39(3):241-249. [9] 方梦蝶,刘波,刘伟. 自噬的分子细胞机制研究进展[J]. 中国细胞生物学学报,2012,34(4):382-390. [10] Townsend KN, Hughson LR, SchlieK, et al. Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity[J].Immunol Rev,2012,249(1),176-194. [11] Deretic V. Autophagy: an emerging immunological paradigm[J]. J Immunol,2012,189(1),15-20. [12] Park S, Buck MD, Desai C, et al. Autophagy genes enhance murine gammaherpesvirus 68 reactivation from latency by preventing birus-induced systemic inflammation[J]. Cell Host Microbe,2016,19(1),91-101. [13] Mario G, Niso-Santano M, Baehrecke EH, et al. Self-consumption: the interplay of autophagy and apoptosis[J]. Nat Rev Mol Cell Biol,2014,15(2):81-94. [14] 潘半舟,封冰,宋海珠. 自噬在调控抗肿瘤药物耐药中的研究进展[J]. 医学研究生学报,2012,25(12):1302-1307. [15] 张海亮,唐圣松. 细胞自噬与肿瘤耐药[J]. 中国生物化学与分子生物学报,2014,30(3):224-232. [16] 张甘霖,杨国旺,于明薇,等. 自噬——中医药抗肿瘤研究的新方向[J]. 中华中医药杂志,2014,29(2):507-510. [17] Zhang L, Li J, Ouyang L, et al. Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy[J]. Cancer Lett,2016,373(1):19-26. [18] Tang JC, Feng YL, Liang X, et al. Autophagy in 5-Fluorouracil therapy in gastrointestinal cancer:Trends and challenges[J].Chin Med J(Engl),2016,129(4),456-463. [19] Dhingra N, Bhagwat D. Benign prostatic hyperplasia: An overview of existing treatment[J]. Indian J Pharmacol,2011,43(1):6-12. [20] McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia[J]. J Urol,2011,185(5):1793-1803. [21] McConnell JD, BruskewitzR, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia[J]. N Engl J Med,1998,338(9),557-563. [22] Li M,Yang X,Wang H, et al. Inhibition of androgen induces autophagy in benign prostate epithelial cells[J]. Int J Urol,2014,21(2):195-199. [23] 朱圣生,吴建辉,孙祖越. 良性前列腺增生发病机制的研究进展[J]. 毒理学杂志,2013,27(5),387-390. [24] Kaini RR, Hu CA. Synergistic killing effect of chloroquine and androgen deprivation in LNCaP cells[J]. Biochem Biophys Res Commun,2012,425(2),150-156. [25] Li M, Jiang X, Liu D, et al. Autophagy protects LNCaP cells under androgen deprivation conditions[J]. Autophagy,2008,4(1),54-60. [26] JiangQ,YehS,WangX,et al. Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy[J]. J Urol,2012,188(4),1361-1368. [27] Lozy F, Karantza V. Autophagy and cancer cell metabolism[J]. Semin Cell Dev Biol,2012,23(4),395-401. [28] Ziparo E, Petrungaro S, Marini ES, et al. Autophagy in prostate cancer and androgen suppression therapy[J]. Int J Mol Sci,2013,14(6),12090-12106. [29] 汤智平,关中. 自噬调节与肿瘤治疗相关的研究进展[J]. 中华肿瘤防治杂志,2013,20(06):477-480. [30] Cheong H, Lu C, Lindsten T, et al. Therapeutic targets in cancer cell metabolism and autophagy[J]. Nat Biotechnol,2012,30(7):671-678. [31] 王树彦,周易明,陈宗祐. 自噬与肿瘤的发生和治疗研究进展[J]. 复旦学报(医学版),2008,35(6):928-931,934. |
[1] |
解加泳 朱强 高建民 陈伟 徐燕. 丹参静脉滴注对早期糖尿病肾病患者外周血自噬相关蛋白表达的影响[J]. 医学临床研究, 2016, 33(3): 447-449. |
[2] |
尤龙飞;丁木亮;倪江东. lncRNA在骨肉瘤中的研究进展[J]. 医学临床研究, 2016, 33(10): 1993-1997. |
[3] |
郑航;李长建;李军;靳全恒;窦启锋. 非那雄胺联合间歇性雄激素阻断治疗晚期前列腺癌40例疗效观察[J]. 医学临床研究, 2016, 33(10): 2040-2042. |
[4] |
蔡崇岳 伍彩云 杨宇峰 李宋荣 史向民 莫仰骐 郑志涛. CD147蛋白在前列腺癌中的表达及临床意义[J]. 医学临床研究, 2015, 32(11): 2088-2090. |
[5] |
郭琼%严彬%南小新%易路%杨金瑞%傅发军. miRNA-29b在前列腺癌中的表达及意义[J]. 医学临床研究, 2015, 32(1): 42-44. |
[6] |
谢彪%陈金辉%刘斌%舒国顺. 5-Aza诱导胃癌细胞株GC-7901凋亡及自噬的相关性研究[J]. 医学临床研究, 2015, 32(1): 57-60. |
[7] |
江明宏%曹雪滨. 快速性室性心律失常的药物治疗进展[J]. 医学临床研究, 2015, 32(1): 181-184,185. |
[8] |
范健睿(综述)%夏昕晖(审校). 尿酸结石临床危险因素的研究现状[J]. 医学临床研究, 2015, 32(1): 185-187. |
[9] |
武亚磊(综述)%姜维良(审校). Notch信号通路与腹主动脉瘤关系的研究进展[J]. 医学临床研究, 2015, 32(1): 188-190. |
[10] |
张洪雨(综述)%刘志鑫%李兆鹏%刘建宇(审校). 肌源干细胞的研究进展[J]. 医学临床研究, 2015, 32(1): 191-193,194. |
[11] |
杨妤%朱道奇(综述)%苏加利(审校). S-1在胰腺癌治疗中的研究进展[J]. 医学临床研究, 2015, 32(1): 194-198. |
[12] |
邓伟捷(综述)%郑维蓬%魏合伟(审校). 关节镜下自体腘绳肌腱重建前交叉韧带术后骨道增宽研究进展[J]. 医学临床研究, 2015, 32(1): 170-172. |
[13] |
夏为%董士民. 微小RNA在急性肺损伤中的研究进展[J]. 医学临床研究, 2015, 32(1): 173-176. |
[14] |
黄涛涛(综述)%祝青国(审校). miRNAs在肾移植中的应用价值[J]. 医学临床研究, 2015, 32(1): 177-180. |
[15] |
宾捷(综述)%卢吉平(审校). 乳腺癌癌因性疲乏的研究进展[J]. 医学临床研究, 2014, 31(8): 1594-1597. |
|
|
|
|